نتایج جستجو برای: herpes simplex virus type 2

تعداد نتایج: 3753147  

2003
KATHRYN LEARY

Hydroxyurea-resistant (HUD) baby hamster kidney cells were isolated, subcloned, and characterized. One clonal line, which contained elevated levels of ribonucleotide reductase, lost its HU resistance during passage in the absence of the inhibitor, whereas another clonal line was stably resistant. The replication of herpes simplex virus type 1 on these cells was compared with that of the parvovi...

2013
Mar Masiá Catalina Robledano Victoria Ortiz de la Tabla Pedro Antequera Natividad López Félix Gutiérrez

OBJECTIVE We investigated the relationship of the Herpesviridiae with inflammation and subclinical atherosclerosis in HIV-infected patients. METHODS Prospective study including virologically suppressed HIV-infected patients. IgG antibodies against herpesviruses, carotid intima-media thickness (cIMT), endothelial function through flow-mediated dilatation (FMD) of the brachial artery, and blood...

Maryam Tarighati, Sharareh Moghim Vajihe Karbasizade

Herpetic keratitis which is resulted from herpes simplex virus type I, is considered the most common cause of corneal blindness that needs being diagnosed and treated in order to prevent irreversible eye effects. The best method to diagnose it is molecular method which has high sensitivity and exclusivity. The current study was done on 25 eye samples collected from patients referred to the Feyz...

Journal: :journal of applied pharmaceutical science 2023

Seroprevalence of Ig G and M Antibodies in Individuals with Herpes Simplex Virus -1 &2 Infection HIV Positive Negative South Indian PopulationSubha Priya Venkateshwaran, Kamaraj Murugesan, Rajeshwari Sivaraj

Journal: :iranian journal of virology 0
j omidian department of ophthalmology, faculty of medicine, kermanshah university of medical sciences, kermanshah, iran f sheikhi-shooshtari department of ophthalmology, faculty of medicine, kermanshah university of medical sciences, kermanshah, iran m fazeli

abstract background and aims: herpes simplex virus (hsv) is a common cause of corneal disease and is the leading infectious cause of corneal blindness among developed nations. this study is aimed to provide an estimation of the incidence of herpes simplex virustype-1, 2(hsv1, 2) and varicella zoster virus (vzv) in tears and swab from eye infection by polymerase chain reaction (pcr) in eye disea...

2016
Jacqueline Le Goaster Patrice Bouree Franck N. El Sissy Florence Phuong Bui Johanna Pokossy Epee Paul Rollin Frédéric Tangy Anne-Lise Haenni

INTRODUCTION At the onset of the 20th century, ancient clinical observations of cancer epidemics in Bantu populations of Sub-Saharan Africa were discovered. They were reported from 1914 to 1960, but remained unexplained. In 1983, in San Francisco, Calif., USA, cancer epidemics were related to infections by the human immunodeficiency virus type 1 (HIV-1) known as AIDS disease. Yet since 1996, it...

Journal: :Journal of virology 1989
S L Deshmane N W Fraser

Latent herpes simplex virus type 1 DNA has a nucleosomal structure similar to that of cellular chromatin, as determined by micrococcal nuclease digestion. All of the major regions, including the transcriptionally active region of the genome, were found to be associated with nucleosomes. Such a chromatin structure is likely to be an important element in the control of herpes simplex virus type 1...

Journal: :Journal of virology 1982
L Pereira D Dondero B Roizman

We recently reported (Pereira et al., Proc. Natl. Acad. Sci. U.S.A. 78:5202-5206, 1981) that herpes simplex virus 1 and 2 glycoproteins, previously designated gA and gB, could not be differentiated by a bank of independently derived type-specific and type-common monoclonal antibodies. We also reported that from lysates of infected Vero cells, all but one monoclonal antibody precipitated gA/B gl...

Journal: :Journal of virology 1997
J A Carr J Rogerson M J Mulqueen N A Roberts R F Booth

The prophylactic and therapeutic efficacy of interleukin-12 was studied by using murine models of herpes simplex virus infection. Prophylactic administration consisted of two intraperitoneal doses of interleukin-12 given 48 and 24 h prior to infection. Therapeutic intraperitoneal administration of interleukin-12 commenced 6 h after the mice were infected with herpes simplex virus and was contin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید